Immunotherapy and Behavioural Immunity
Behavioural immunity that allow individual organisms to detect the possible presence of disease-causing parasites in their instant environment, and to seize in behaviours which prevent contact with those objects and individuals. The treatment using components of the immune system or antigens for immune disorders is called immunotherapy. Immunotherapy can activate or supress the immune system. Immunotherapies that activate the immune response are called activation immunotherapies. Immunotherapies that suppress the immune system are called suppression immunotherapies.
Immunotherapy is mainly used to treat:
- Allergies
- Autoimmune disorders
- Cancers
Related Conference of Immunotherapy and Behavioural Immunity
December 21-22, 2026
7th World Congress on Neuroimmunology and Neuroinfectious Diseases
Paris, France
Immunotherapy and Behavioural Immunity Conference Speakers
Recommended Sessions
- Immune Disorders
- Allergic Contact Dermatitis
- Allergic Rhinitis
- Allergy and Inflammation
- Anaphylaxis and Asthma
- Autoimmune Diseases
- Cancer Immunology
- Clinical Immunology
- Coronavirus and SARS-CoV-2
- Developmental Immunology
- Food Allergy and Drug Allergy
- Immune System and Allergic Reactions
- Immunopathology of COVID 19
- Immunotherapy and Behavioural Immunity
- Market and Future of Therapeutics
- Molecular Allergology and Allergy Diagnostics
- Neonatal and Pediatric Immunology
- Oral Allergy Syndrome
- Oral Immunotherapy and Allergen Immunotherapy
- Vaccination and Immunisation
- Veterinary Allergology
Related Journals
Are you interested in
- Advances in Neuroimaging and Diagnostic Techniques - Neuroimmunology Congress 2026 (France)
- Advances in Neuroimmunology and Neuroinflammation - Neuroimmunology Congress 2026 (France)
- Artificial Intelligence and Data-Driven Approaches in Neuroimmunology - Neuroimmunology Congress 2026 (France)
- Autoimmune Neurological Disorders and Therapeutic Advances - Neuroimmunology Congress 2026 (France)
- Biomarkers and Precision Medicine in Neuroimmune Disorders - Neuroimmunology Congress 2026 (France)
- Case Studies and Clinical Practice in Neuroimmunology and Neuroinfectious Diseases - Neuroimmunology Congress 2026 (France)
- Clinical Trials and Drug Development in Neuroimmunology - Neuroimmunology Congress 2026 (France)
- CNS Infections: Diagnosis, Management, and Prevention - Neuroimmunology Congress 2026 (France)
- Emerging Technologies and Future Directions in Neuroimmunology - Neuroimmunology Congress 2026 (France)
- Ethical Considerations and Future Perspectives in Neuroimmunology Research - Neuroimmunology Congress 2026 (France)
- Immunogenetics and Neuroimmune Interactions - Neuroimmunology Congress 2026 (France)
- Immunotherapy and Novel Treatment Strategies - Neuroimmunology Congress 2026 (France)
- Microbiome and the Gut-Brain-Immune Axis - Neuroimmunology Congress 2026 (France)
- Neurodegeneration and Immune System Interactions - Neuroimmunology Congress 2026 (France)
- Neuroimmunology in Pediatric Disorders - Neuroimmunology Congress 2026 (France)
- Neuroinfectious Diseases and Global Health Challenges - Neuroimmunology Congress 2026 (France)
- Public Health, Policy, and Global Collaboration in Neuroimmunology - Neuroimmunology Congress 2026 (France)
- Rehabilitation and Long-Term Management of Neuroimmune Disorders - Neuroimmunology Congress 2026 (France)
- Translational Research and Clinical Applications in Neuroimmunology - Neuroimmunology Congress 2026 (France)
- Young Researchers, Innovation, and Emerging Ideas - Neuroimmunology Congress 2026 (France)
